Title:
PHARMACEUTICAL COMPOSITION CONTAINING HUMANIZED ANTI-HUMAN IL-17A MONOCLONAL ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2021/058005
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition containing a humanized anti-human IL-17A monoclonal antibody, comprising: (a) an anti-human IL-17A monoclonal antibody; and (b) a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier comprises a buffer solution, a stabilizer, and a surfactant.
Inventors:
JIA HUIFENG (CN)
CAI MINGQING (CN)
PAN XIANFEI (CN)
WANG SHAOJIE (CN)
ZHU XIANGYANG (CN)
CAI MINGQING (CN)
PAN XIANFEI (CN)
WANG SHAOJIE (CN)
ZHU XIANGYANG (CN)
Application Number:
PCT/CN2020/118477
Publication Date:
April 01, 2021
Filing Date:
September 28, 2020
Export Citation:
Assignee:
HUABO BIOPHARM SHANGHAI CO LTD (CN)
International Classes:
A61K39/395; A61K9/19; A61K47/12; A61K47/26; A61P1/00; A61P3/10; A61P17/06; A61P19/02; A61P19/08; A61P25/00; A61P29/00; A61P37/02
Domestic Patent References:
WO2019085982A1 | 2019-05-09 |
Foreign References:
CN110585430A | 2019-12-20 | |||
CN107257692A | 2017-10-17 | |||
CN107257692A | 2017-10-17 | |||
CN108359011A | 2018-08-03 | |||
CN108671229A | 2018-10-19 | |||
CN109310628A | 2019-02-05 | |||
CN105431453A | 2016-03-23 |
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: